SPATA5-related disorder (NEDCAS) presents with earlier seizure onset, more pronounced microcephaly, and frequent movement disorders [5], whereas SPATA5L1-associated cases appear to manifest more consistently with spastic-dystonic cerebral palsy and hearing loss [1]. The gene discussed is AFG2B; the disease is neurodevelopmental disorder with cerebellar atrophy and with or without seizures.